Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Semaglutide, the first dedicated GLP-1 obesity treatment, achieved 14.9% body weight reduction in the STEP 1 trial
For Canadians dealing with post-weight-loss skin laxity, injectable GHK-Cu offers a non-surgical option backed by over 40 years of scientific research and a strong safety profile
Injectable peptides, in general, are not without side effects, either
BPC-157 is supplied as a lyophilized powder and in capsules form
US$ 22.81
US$ 26.13
US$ 24.23
US$ 21.88
US$ 20.87
US$ 26.75
US$ 25.84
